Artelo Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th Mar 02, 2021 8:30am EST
Artelo Biosciences Announces Positive Pre-Clinical Data Associated with Proprietary CBD Cocrystal Feb 17, 2021 8:30am EST
Artelo Biosciences Announces Appointment of Andrew Yates, Ph.D. as Senior Vice President and Chief Scientific Officer Feb 16, 2021 8:30am EST
Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants Feb 08, 2021 8:30am EST
Artelo Biosciences Announces Research Collaboration with Trinity College Dublin to Investigate ART27.13 for the Treatment of Cancer Cachexia Feb 02, 2021 8:30am EST
Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Update Jan 14, 2021 8:30am EST
Artelo Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference Jan 05, 2021 8:30am EST
Artelo Biosciences to Present at The 13th Annual LD Micro Main Event Conference on December 15th Dec 08, 2020 8:30am EST
